Keywords : Neonatal Morbidity
ASSESSMENT OF THE SEVERE ANAEMIA PREVALENCE AND ASSOCIATED FETO-MATERNAL OUTCOMES IN FEMALES ADMITTED FOR LABOR: A PROSPECTIVE CLINICAL STUDY
European Journal of Molecular & Clinical Medicine,
2021, Volume 8, Issue 4, Pages 2367-2372
Background: There exists a high prevalence of anaemia in pregnant females owing to
multiparity, close birth spacing, lack of appropriate antenatal care, low socioeconomic status,
ignorance, and illiteracy.
Objectives: The present study was conducted to assess the incidence of severe anaemia with
having hemoglobin of less than7gm% in pregnant females and to assess the fetal outcomes
following delivery in females having severe anaemia.
Methodology: A total of 1000 pregnant subjects were screened for anaemia. The pregnant
femaleshavingHb% of <7g% in labor were included and feto-maternal outcomes in these
females were evaluated.
Results: Puerperal complications seen were wound gaping, episiotomy, lactation failure, sub
involution, sepsis, and pyrexia in 2.46% (n=2), 2.46% (n=2), 8.64% (n=7), 7.40% (n=6),
2.46% (n=2), and 7.40% (n=6) subjects respectively in severe anaemia group, and in 12.12%
(n=4), 3.03% (n=1), 15.15% (n=5), 18.18% (n=6), 6.06% (n=2), and 9.09% (n=3) subjects
respectively with very severe anaemia. Mortality was seen in 3.03% (n=1) subject with very
severe anaemia. Morbidity was seen in 27.16% (n=22) subjects with severe anaemia and in
45.45% (n=15) subjects with very severe anaemia. The fetal outcomes were also evaluated in
the study subjects. Low birth weight was seen in 7.40% (n=6) subjects with severe anaemia
and in 6.06% (n=2) subjects with very severe anaemia. Neonatal mortality and morbidity was
seen in 1.23% (n=1) and 13.58% (n=11) subjects respectively with severe anaemia, and in
6.06% (n=2) and 24.24% (n=8) subjects respectively with very severe anaemia. Fetal
complications seen in the present study were birthaplasia in 1.23% (n=1) and 3.03% (n=1)
subject with severe and very severe anaemia respectively, sepsis in 1.23% (n=1) and 3.03%
(n=1) subject with severe and very severe anaemia respectively, and IUGR in 1.23% (n=1)
subject with severe anaemia.